Pearson Pharma Partners

Pearson Pharma Partners is a for-profit S Corporation based in Westlake Village, California, specializing in pharmaceutical consulting services, specifically in the domain of Drug Metabolism and Pharmacokinetics (DMPK). Registered in the System for Award Management (SAM.gov) since June 2011, the company provides subject matter expert consulting services to federal agencies, with a particular focus on supporting neuroscience research initiatives. The firm's expertise appears centered on providing high-level scientific consulting to national research institutions, leveraging deep technical knowledge in pharmacological research and development.

The company has secured multiple federal contract awards from prominent National Institutes of Health (NIH) agencies, specifically the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute on Drug Abuse (NIDA). These contracts, ranging from $24,000 to $532,500, are primarily purchase order agreements for DMPK consulting support services. Two of the three contracts were set aside for small businesses, indicating the company's status as a small business enterprise. The contracts involve providing senior-level DMPK consultants who advise on study design, data analysis, and project milestones for the Blueprint Neurotherapeutics Program and other neuroscience initiatives. The consulting work is predominantly performed remotely, with occasional travel to NIH facilities in Bethesda, Maryland, and focuses on supporting the development of new treatments for neurological disorders through expert scientific guidance.